Whitehawk Therapeutics, Inc. (WHWK) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Whitehawk Therapeutics, Inc. (WHWK) closed at USD 2.97 on 2026-10-14, a change of +23.7 % over the past year, with a market capitalization of USD 173.31M.

Whitehawk Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Whitehawk Therapeutics, Inc. key figures

Previous close

USD 2.97 (2026-10-14)

1-year change

+23.7 %

Market cap

USD 173.31M

Enterprise value

USD -16.67M

P/E ratio (trailing)

-2.67

P/E ratio (forward)

-3.08

EPS (trailing)

-1.14

EPS (forward)

-0.99

PEG ratio

n/a

Price to book

0.95

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.89

Employees

32

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Whitehawk Therapeutics, Inc. and compare it with other stocks.